Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621594 · ClinicalTrials.gov registry record · NA
Evaluating New Radiation Techniques for Cardiovascular Imaging
A NA study of Coronary Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT01621594 is a NA study of Coronary Disease that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,000 participants, above the 1,872-participant average among 34 other Coronary Disease trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01621594, a NA study of Coronary Disease, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Title: Evaluating New Radiation Techniques for Cardiovascular Imaging Background: Cardiac CT angiography is associated with radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose to the subject. The purpose of this research study is to learn whether these low dose research imagings are accurate or predict subject outcomes. Cardiac CT is also used for diagnostic imaging of coronary artery disease and identification of abnormal cardiac structures. An additional purpose of this study is to monitor the progression of cardiac disease. Cardiac imaging software and AI are constantly evolving and requires validation for accuracy. Using existing scan data, updated image software reconstruction can be applied and compared to previous existing standard of care images. Objectives: \- To study new ways of taking pictures of the heart or blood vessels using computed tomography. Eligibility: \- Adults at least 18 years of age who will be having imaging studies to help detect heart or blood vessel problems. Design: * Participants will be screened with a physical exam and medical history. Blood samples will be taken to check kidney function. * Participants will have a CT scan of the heart and blood vessels. A contrast agent may be used to improve the quality of the images. The scanning session may last up to 2 hours. * Timing of and the need for follow up contact will depend on results from the initial scan and may be repeated to assess for late events. Telephone, office contact, or other follow-up of subjects may be done after CCTA to evaluate if the subject had subsequent cardiovascular testing. Further follow up will be based on reported test results.
Conditions Studied
Interventions
- DEVICE Cannon Aquilion ONE CT system
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2012-06-21 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621594
The ClinicalTrials.gov registry entry for NCT01621594 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,872-participant average among 34 other Coronary Disease trials with a reported enrollment target (167% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Disease appearing as the primary indexed condition, and to 1 intervention - of which Cannon Aquilion ONE CT system is the first listed.
NCT01621594 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01621594 about?
NCT01621594 is a clinical study titled "Evaluating New Radiation Techniques for Cardiovascular Imaging". Title: Evaluating New Radiation Techniques for Cardiovascular Imaging Background: Cardiac CT angiography is associated with radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose to the subject. The purpose of this research study is to learn ...
What is the current status of trial NCT01621594?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2012-06-21. Estimated completion is 2027-04-01.
What conditions does trial NCT01621594 study?
This clinical trial studies the following conditions: Coronary Disease.
What interventions are being tested in trial NCT01621594?
The interventions under investigation include: Cannon Aquilion ONE CT system (DEVICE).
Who is sponsoring clinical trial NCT01621594?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01621594 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sapphire 3 CTO Study
COMPLETED · NA
-
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
COMPLETED · NA
-
Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
COMPLETED · NA
-
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
COMPLETED · NA
-
Time Restricted Feeding for Weight Loss and Cardio-protection
COMPLETED · NA
-
Collaborative Cardiac Care Project
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.